CBU
IRWD icon

CIBC Bancorp USA’s Ironwood Pharmaceuticals IRWD Stock Holding History

CIBC Bancorp USA’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$22.3K Buy
+17,056
New +$17.7K ﹤0.01% 1452

Other funds holding IRWD

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

CIBC Bancorp USA's IRWD Position: Q3 2025 in Review

CIBC Bancorp USA opened a new position in Ironwood Pharmaceuticals (IRWD) in Q3 2025: 17,056 shares worth $22.3K. The stake represents ﹤0.01% of the portfolio and ranks #1452 among its holdings.

166 funds tracked by Wall St. Rank hold IRWD as of Q3 2025.

  • CIBC Bancorp USA held 17,056 shares of Ironwood Pharmaceuticals worth $22.3K as of Q3 2025.
  • Ironwood Pharmaceuticals was a new CIBC Bancorp USA position in Q3 2025.
  • Ironwood Pharmaceuticals made up ﹤0.01% of CIBC Bancorp USA's portfolio in Q3 2025, its #1452 holding.
  • 166 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q3 2025.

Based on CIBC Bancorp USA's 13F filing for Q3 2025, filed 12 Nov 2025.